首页 > 最新文献

Journal of Laryngology and Otology最新文献

英文 中文
Our experience of a speech and language therapist-led swallow disorder clinic. 我们在言语和语言治疗师领导下的吞咽障碍诊所的经验。
IF 1.1 4区 医学 Q3 OTORHINOLARYNGOLOGY Pub Date : 2024-12-01 Epub Date: 2024-04-30 DOI: 10.1017/S0022215124000859
Joseph Smith, Anita Smith, Karen McInally, Paul Kirkland

Introduction: Dysphagia can lead to morbidity including weight loss and aspiration pneumonia. Effective triage of patients and streamlining of pathways to expedite diagnosis and treatment is therefore imperative.

Objectives: The goals of this research were to measure the referral to treatment time for dysphagia patients in a newly established pathway and compare with existing UK national and local referral to treatment times, and to evaluate patient feedback.

Methods: Speech and language therapy advanced clinical practitioners were trained in nasendoscopy and assessment of swallow. Referral to treatment times were measured and patient satisfaction questionnaires completed.

Results: A decrease in triage to treatment time (from 24 to 6 weeks). Patients reported high understanding of the condition and minimal discomfort during assessments. Radiation exposure was reduced (2 per cent of patients undergoing soluble contrast swallows, previously 100 per cent).

Conclusion: The new pathway expedites treatment and achieves high patient satisfaction. It empowers speech and language therapy in efficiently managing low-complexity cases and supports multidisciplinary care for dysphagia patients.

吞咽困难可导致包括体重减轻和吸入性肺炎在内的疾病。因此,必须对患者进行有效分诊并简化途径,以加快诊断和治疗。目的:本研究的目的是在新建立的途径中测量吞咽困难患者的转诊到治疗时间,并与现有的英国国家和地方转诊到治疗时间进行比较,并评估患者反馈。方法:对语言治疗高级临床医师进行鼻内镜检查和吞咽评估培训。测量转诊治疗次数并完成患者满意度问卷。结果:分诊至治疗时间缩短(由24周缩短至6周)。在评估期间,患者报告了对病情的高度理解和最小的不适。辐射暴露减少了(接受可溶性造影剂注射的患者为2%,之前为100%)。结论:新途径加快了治疗速度,患者满意度高。它使语音和语言治疗有效地管理低复杂性的病例,并支持吞咽困难患者的多学科护理。
{"title":"Our experience of a speech and language therapist-led swallow disorder clinic.","authors":"Joseph Smith, Anita Smith, Karen McInally, Paul Kirkland","doi":"10.1017/S0022215124000859","DOIUrl":"10.1017/S0022215124000859","url":null,"abstract":"<p><strong>Introduction: </strong>Dysphagia can lead to morbidity including weight loss and aspiration pneumonia. Effective triage of patients and streamlining of pathways to expedite diagnosis and treatment is therefore imperative.</p><p><strong>Objectives: </strong>The goals of this research were to measure the referral to treatment time for dysphagia patients in a newly established pathway and compare with existing UK national and local referral to treatment times, and to evaluate patient feedback.</p><p><strong>Methods: </strong>Speech and language therapy advanced clinical practitioners were trained in nasendoscopy and assessment of swallow. Referral to treatment times were measured and patient satisfaction questionnaires completed.</p><p><strong>Results: </strong>A decrease in triage to treatment time (from 24 to 6 weeks). Patients reported high understanding of the condition and minimal discomfort during assessments. Radiation exposure was reduced (2 per cent of patients undergoing soluble contrast swallows, previously 100 per cent).</p><p><strong>Conclusion: </strong>The new pathway expedites treatment and achieves high patient satisfaction. It empowers speech and language therapy in efficiently managing low-complexity cases and supports multidisciplinary care for dysphagia patients.</p>","PeriodicalId":16293,"journal":{"name":"Journal of Laryngology and Otology","volume":" ","pages":"1130-1132"},"PeriodicalIF":1.1,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140870540","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adjuvant treatments for recurrent respiratory papillomatosis: a descriptive review and proposed management guideline in adults. 复发性呼吸道乳头状瘤病的辅助治疗:描述性综述和成人管理指南建议。
IF 1.1 4区 医学 Q3 OTORHINOLARYNGOLOGY Pub Date : 2024-12-01 Epub Date: 2024-10-21 DOI: 10.1017/S0022215124001026
Edward Balai, Emilie Ac Dronkers, Chadwan A Yaghchi, Dorothy Gujral, Guri Sandhu, Aphrodite Iacovidou

Objective: Recurrent respiratory papillomatosis is a rare disease characterised by growth of papilloma within the respiratory tract. The disease course is variable but can require frequent surgical interventions alongside adjuvant medical treatments. There is no definitive curative treatment or gold-standard guidelines for management. We aimed to evaluate current and potential future adjuvant treatments and propose a management guideline for adult patients.

Methods: Relevant articles were identified through searching databases, reference lists and grey literature.

Results: Systemic bevacizumab appears to be the most effective adjuvant treatment currently available. However, intralesional cidofovir also achieves a high complete-response rate in adults and the Gardasil vaccine demonstrates preventative and therapeutic value. The INO-3107 DNA vaccine is a promising potential future adjuvant treatment.

Conclusions: This review provides a detailed examination of current and potential future adjuvant treatments. Based on the literature, we have developed a management guideline for adult patients with recurrent respiratory papillomatosis.

目的:复发性呼吸道乳头状瘤病是一种以呼吸道内乳头状瘤生长为特征的罕见疾病。病程是可变的,但可能需要频繁的手术干预和辅助药物治疗。目前还没有确定的治疗方法或黄金标准的管理指南。我们旨在评估当前和潜在的未来辅助治疗,并提出成人患者的管理指南。方法:通过检索数据库、参考文献表、灰色文献等方法对相关文献进行筛选。结果:全身贝伐单抗似乎是目前可用的最有效的辅助治疗。然而,病变内西多福韦在成人中也达到了很高的完全缓解率,加德西疫苗显示出预防和治疗价值。INO-3107 DNA疫苗是一种很有前途的未来辅助治疗方法。结论:本综述提供了当前和潜在的未来辅助治疗的详细检查。在文献的基础上,我们制定了成人复发性呼吸道乳头状瘤病的治疗指南。
{"title":"Adjuvant treatments for recurrent respiratory papillomatosis: a descriptive review and proposed management guideline in adults.","authors":"Edward Balai, Emilie Ac Dronkers, Chadwan A Yaghchi, Dorothy Gujral, Guri Sandhu, Aphrodite Iacovidou","doi":"10.1017/S0022215124001026","DOIUrl":"10.1017/S0022215124001026","url":null,"abstract":"<p><strong>Objective: </strong>Recurrent respiratory papillomatosis is a rare disease characterised by growth of papilloma within the respiratory tract. The disease course is variable but can require frequent surgical interventions alongside adjuvant medical treatments. There is no definitive curative treatment or gold-standard guidelines for management. We aimed to evaluate current and potential future adjuvant treatments and propose a management guideline for adult patients.</p><p><strong>Methods: </strong>Relevant articles were identified through searching databases, reference lists and grey literature.</p><p><strong>Results: </strong>Systemic bevacizumab appears to be the most effective adjuvant treatment currently available. However, intralesional cidofovir also achieves a high complete-response rate in adults and the Gardasil vaccine demonstrates preventative and therapeutic value. The INO-3107 DNA vaccine is a promising potential future adjuvant treatment.</p><p><strong>Conclusions: </strong>This review provides a detailed examination of current and potential future adjuvant treatments. Based on the literature, we have developed a management guideline for adult patients with recurrent respiratory papillomatosis.</p>","PeriodicalId":16293,"journal":{"name":"Journal of Laryngology and Otology","volume":" ","pages":"1133-1143"},"PeriodicalIF":1.1,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142467688","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tinnitus and dementia risk, adjuvant treatments for recurrent respiratory papillomatosis and is frontal sinus pain a useful marker of chronic frontal sinusitis? 耳鸣和痴呆的风险,复发性呼吸道乳头状瘤病的辅助治疗,额窦疼痛是慢性额窦炎的有用标志吗?
IF 1.1 4区 医学 Q3 OTORHINOLARYNGOLOGY Pub Date : 2024-12-01 Epub Date: 2025-01-15 DOI: 10.1017/S0022215124002317
Jonathan Fishman, Edward W Fisher
{"title":"Tinnitus and dementia risk, adjuvant treatments for recurrent respiratory papillomatosis and is frontal sinus pain a useful marker of chronic frontal sinusitis?","authors":"Jonathan Fishman, Edward W Fisher","doi":"10.1017/S0022215124002317","DOIUrl":"https://doi.org/10.1017/S0022215124002317","url":null,"abstract":"","PeriodicalId":16293,"journal":{"name":"Journal of Laryngology and Otology","volume":"138 12","pages":"1119"},"PeriodicalIF":1.1,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142983814","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Outcomes of the modern management approach for locally advanced (T3-T4) laryngeal cancer: a retrospective cohort study. 局部晚期(T3-T4)喉癌现代治疗方法的疗效:一项回顾性队列研究。
IF 1.1 4区 医学 Q3 OTORHINOLARYNGOLOGY Pub Date : 2024-12-01 Epub Date: 2024-10-21 DOI: 10.1017/S0022215124001105
Amarkumar Dhirajlal Rajgor, Josh Cowley, Colin Gillespie, Chang Woo Lee, James O'Hara, Muhammad Shahid Iqbal, David Winston Hamilton

Background: Our centre (Freeman Hospital, Newcatle Upon Tyne NHS Trust) has favoured primary surgery over chemoradiotherapy for specific advanced laryngeal cancer patients (e.g. large-volume tumours, airway compromise, significant dysphagia, T4 disease). This study reports the survival outcomes for a modern, high-volume head and neck centre favouring surgical management to determine whether this approach improves survival.

Method: Retrospective analysis of patient data over a seven-year period from a tertiary cancer centre.

Results: In total, 121 patients were identified with T3 (n = 76) or T4 (n = 45) laryngeal cancer (mean follow up 2.9 years). In the cohort treated with curative intent (n = 104, 86.0 per cent), the 2- and 5-year estimated disease-specific survival rates were 77.9 and 64.1 per cent. chemoradiotherapy had the highest 2-year disease-specific survival (92.5 per cent), followed by surgery with adjuvant therapy (81.8 per cent), radiotherapy alone (75 per cent) and surgery alone (72.4 per cent).

Conclusion: For a centre favouring primary surgery for certain advanced laryngeal cancers, the disease-specific survival appears no higher than that found in the published literature. To enhance survival, future research should focus on precision medicine to define treatment pathways in this disease.

背景:我们的中心(Freeman医院,Newcatle Upon Tyne NHS Trust)对于特定的晚期喉癌患者(如大体积肿瘤,气道受损,严重吞咽困难,T4疾病)更倾向于初级手术而不是放化疗。本研究报告了现代大容量头颈部中心的生存结果,以确定手术治疗是否能提高生存率。方法:回顾性分析某三级肿瘤中心7年的患者资料。结果:121例患者确诊为T3(76例)或T4(45例)喉癌(平均随访2.9年)。在以治疗目的治疗的队列中(n = 104, 86.0%), 2年和5年的估计疾病特异性生存率分别为77.9%和64.1%。放化疗的2年疾病特异性生存率最高(92.5%),其次是手术辅助治疗(81.8%),单独放疗(75%)和单独手术(72.4%)。结论:对于一个支持对某些晚期喉癌进行原发性手术的中心来说,疾病特异性生存率似乎并不高于已发表的文献。为了提高生存率,未来的研究应侧重于精准医学,以确定该疾病的治疗途径。
{"title":"Outcomes of the modern management approach for locally advanced (T<sub>3</sub>-T<sub>4</sub>) laryngeal cancer: a retrospective cohort study.","authors":"Amarkumar Dhirajlal Rajgor, Josh Cowley, Colin Gillespie, Chang Woo Lee, James O'Hara, Muhammad Shahid Iqbal, David Winston Hamilton","doi":"10.1017/S0022215124001105","DOIUrl":"10.1017/S0022215124001105","url":null,"abstract":"<p><strong>Background: </strong>Our centre (Freeman Hospital, Newcatle Upon Tyne NHS Trust) has favoured primary surgery over chemoradiotherapy for specific advanced laryngeal cancer patients (e.g. large-volume tumours, airway compromise, significant dysphagia, T<sub>4</sub> disease). This study reports the survival outcomes for a modern, high-volume head and neck centre favouring surgical management to determine whether this approach improves survival.</p><p><strong>Method: </strong>Retrospective analysis of patient data over a seven-year period from a tertiary cancer centre.</p><p><strong>Results: </strong>In total, 121 patients were identified with T<sub>3</sub> (<i>n</i> = 76) or T<sub>4</sub> (<i>n</i> = 45) laryngeal cancer (mean follow up 2.9 years). In the cohort treated with curative intent (<i>n</i> = 104, 86.0 per cent), the 2- and 5-year estimated disease-specific survival rates were 77.9 and 64.1 per cent. chemoradiotherapy had the highest 2-year disease-specific survival (92.5 per cent), followed by surgery with adjuvant therapy (81.8 per cent), radiotherapy alone (75 per cent) and surgery alone (72.4 per cent).</p><p><strong>Conclusion: </strong>For a centre favouring primary surgery for certain advanced laryngeal cancers, the disease-specific survival appears no higher than that found in the published literature. To enhance survival, future research should focus on precision medicine to define treatment pathways in this disease.</p>","PeriodicalId":16293,"journal":{"name":"Journal of Laryngology and Otology","volume":" ","pages":"1154-1160"},"PeriodicalIF":1.1,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11735189/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142467730","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The efficacy and safety of radiofrequency ablation for allergic rhinitis: a systematic review and meta-analysis. 射频消融治疗变应性鼻炎的有效性和安全性:一项系统回顾和荟萃分析。
IF 1.1 4区 医学 Q3 OTORHINOLARYNGOLOGY Pub Date : 2024-12-01 Epub Date: 2024-12-04 DOI: 10.1017/S0022215124001178
Xi Zhang, Min Yan, Qicheng Deng, Ling Yang

Objective: This systematic review aims to synthesise findings from randomised, controlled trials and assess the efficacy and safety of radiofrequency ablation in treating allergic rhinitis.

Methods: A thorough search was conducted across PubMed, the Cochrane Library, Embase, Web of Science, China National Knowledge Infrastructure, WanFang, Chinese Scientific Journal, and Chinese Biomedical Literature databases from their inception until October 2023. The primary outcome measure was the total effective rate, with secondary outcomes including adverse events.

Results: This review included 15 randomised, controlled trials involving 1430 patients. The pooled analysis revealed a statistically significant effect on the total effective rate (odds ratio = 3.27, 95 per cent confidence interval = 2.37 to ~4.51). However, no statistical significance was observed in adverse events (odds ratio = 1.18, 95 per cent confidence interval = 0.67 to ~2.08).

Conclusions: Based on the analytical results, radiofrequency ablation emerges as an efficacious and safe treatment modality for allergic rhinitis. Given the constraints posed by a limited sample size, it is imperative that forthcoming clinical trials adhere rigorously to the gold standard of randomised, controlled trials for the purpose of corroborating these conclusions.

目的:本系统综述旨在综合随机对照试验的结果,并评估射频消融治疗变应性鼻炎的有效性和安全性。方法:对PubMed、Cochrane图书馆、Embase、Web of Science、中国国家知识基础设施、万方、中国科学杂志和中国生物医学文献数据库进行全面检索,从数据库建立到2023年10月。主要结局指标是总有效率,次要结局指标包括不良事件。结果:本综述纳入15项随机对照试验,涉及1430例患者。合并分析显示对总有效率有统计学显著影响(优势比= 3.27,95%置信区间= 2.37 ~ ~4.51)。然而,不良事件发生率差异无统计学意义(优势比= 1.18,95%可信区间= 0.67 ~ ~2.08)。结论:基于分析结果,射频消融是一种有效且安全的治疗变应性鼻炎的方法。鉴于有限的样本量所带来的限制,为了证实这些结论,即将进行的临床试验必须严格遵守随机对照试验的黄金标准。
{"title":"The efficacy and safety of radiofrequency ablation for allergic rhinitis: a systematic review and meta-analysis.","authors":"Xi Zhang, Min Yan, Qicheng Deng, Ling Yang","doi":"10.1017/S0022215124001178","DOIUrl":"10.1017/S0022215124001178","url":null,"abstract":"<p><strong>Objective: </strong>This systematic review aims to synthesise findings from randomised, controlled trials and assess the efficacy and safety of radiofrequency ablation in treating allergic rhinitis.</p><p><strong>Methods: </strong>A thorough search was conducted across PubMed, the Cochrane Library, Embase, Web of Science, China National Knowledge Infrastructure, WanFang, Chinese Scientific Journal, and Chinese Biomedical Literature databases from their inception until October 2023. The primary outcome measure was the total effective rate, with secondary outcomes including adverse events.</p><p><strong>Results: </strong>This review included 15 randomised, controlled trials involving 1430 patients. The pooled analysis revealed a statistically significant effect on the total effective rate (odds ratio = 3.27, 95 per cent confidence interval = 2.37 to ~4.51). However, no statistical significance was observed in adverse events (odds ratio = 1.18, 95 per cent confidence interval = 0.67 to ~2.08).</p><p><strong>Conclusions: </strong>Based on the analytical results, radiofrequency ablation emerges as an efficacious and safe treatment modality for allergic rhinitis. Given the constraints posed by a limited sample size, it is imperative that forthcoming clinical trials adhere rigorously to the gold standard of randomised, controlled trials for the purpose of corroborating these conclusions.</p>","PeriodicalId":16293,"journal":{"name":"Journal of Laryngology and Otology","volume":" ","pages":"1120-1129"},"PeriodicalIF":1.1,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142769710","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Deep neck space infections: a UK centre, two-year, retrospective review of 53 cases. 颈深间隙感染:英国一家中心对 53 例病例进行的为期两年的回顾性研究。
IF 1.1 4区 医学 Q3 OTORHINOLARYNGOLOGY Pub Date : 2024-12-01 Epub Date: 2024-10-22 DOI: 10.1017/S0022215124001117
Alexander Charlton, Raul Simon, Karthika Shanthakunalan, Anthony Simons

Objective: This retrospective study comprehensively assesses clinical characteristics, management, outcomes, and complications of deep neck space infections in adults at a UK ear, nose and throat tertiary centre.

Methods: Adult deep neck space infection patients from April 2019 to March 2021 were retrospectively reviewed using health records and picture archiving and communication system data. Demographics, presentation, microbiology, treatment, complications, and outcomes were analysed.

Results: Fifty-three patients (mean age: 53.8 years, M:F ratio 1.5:1) were studied. Deep neck space infections were polymicrobial in 29.4 per cent, with Streptococcus milleri group (64.7 per cent) occurring most frequently. Complications occurred in 20.8 per cent, including mediastinitis (13.2 per cent) and Lemierre's syndrome (7.5 per cent). Mortality was 5.7 per cent. Treatment included intensive care admission (32.1 per cent), tracheostomy (15.1 per cent), medical management alone (39.6 per cent), bedside peritonsillar abscess drainage (18.9 per cent), transcervical drainage (28.3 per cent), transoral drainage (13.2 per cent), and hot tonsillectomy (5.7 per cent). Patient age correlated with length of stay.

Conclusion: The study highlights deep neck space infection complexity, emphasising tailored management, effective antibiotics, and frequency and severity of complications. Comprehensive understanding of deep neck space infections can improve care and outcomes.

目的:本回顾性研究全面评估英国耳、鼻、喉三级中心成人深颈间隙感染的临床特征、处理、结果和并发症。方法:回顾性分析2019年4月至2021年3月成人深颈间隙感染患者的健康记录、图片存档和通信系统数据。分析了人口统计学、临床表现、微生物学、治疗、并发症和结果。结果:共纳入53例患者,平均年龄53.8岁,M:F比1.5:1。深颈间隙感染为多微生物感染(29.4%),以米勒链球菌组(64.7%)发生最频繁。并发症发生率为20.8%,包括纵隔炎(13.2%)和Lemierre综合征(7.5%)。死亡率为5.7%。治疗包括重症监护入院(32.1%)、气管切开术(15.1%)、单独医疗管理(39.6%)、床边膀胱周围脓肿引流(18.9%)、经颈引流(28.3%)、经口引流(13.2%)和扁桃体热切除术(5.7%)。患者年龄与住院时间相关。结论:该研究突出了深颈间隙感染的复杂性,强调了量身定制的管理,有效的抗生素,以及并发症的频率和严重程度。全面了解深颈间隙感染可以改善护理和结果。
{"title":"Deep neck space infections: a UK centre, two-year, retrospective review of 53 cases.","authors":"Alexander Charlton, Raul Simon, Karthika Shanthakunalan, Anthony Simons","doi":"10.1017/S0022215124001117","DOIUrl":"10.1017/S0022215124001117","url":null,"abstract":"<p><strong>Objective: </strong>This retrospective study comprehensively assesses clinical characteristics, management, outcomes, and complications of deep neck space infections in adults at a UK ear, nose and throat tertiary centre.</p><p><strong>Methods: </strong>Adult deep neck space infection patients from April 2019 to March 2021 were retrospectively reviewed using health records and picture archiving and communication system data. Demographics, presentation, microbiology, treatment, complications, and outcomes were analysed.</p><p><strong>Results: </strong>Fifty-three patients (mean age: 53.8 years, M:F ratio 1.5:1) were studied. Deep neck space infections were polymicrobial in 29.4 per cent, with <i>Streptococcus milleri</i> group (64.7 per cent) occurring most frequently. Complications occurred in 20.8 per cent, including mediastinitis (13.2 per cent) and Lemierre's syndrome (7.5 per cent). Mortality was 5.7 per cent. Treatment included intensive care admission (32.1 per cent), tracheostomy (15.1 per cent), medical management alone (39.6 per cent), bedside peritonsillar abscess drainage (18.9 per cent), transcervical drainage (28.3 per cent), transoral drainage (13.2 per cent), and hot tonsillectomy (5.7 per cent). Patient age correlated with length of stay.</p><p><strong>Conclusion: </strong>The study highlights deep neck space infection complexity, emphasising tailored management, effective antibiotics, and frequency and severity of complications. Comprehensive understanding of deep neck space infections can improve care and outcomes.</p>","PeriodicalId":16293,"journal":{"name":"Journal of Laryngology and Otology","volume":" ","pages":"1161-1169"},"PeriodicalIF":1.1,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142467716","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence and risk factors for dysplasia and malignancy in a large cohort of patients with recurrent respiratory papillomatosis. 一大批反复呼吸道乳头状瘤病患者中发育不良和恶性肿瘤的患病率和风险因素。
IF 1.1 4区 医学 Q3 OTORHINOLARYNGOLOGY Pub Date : 2024-11-15 DOI: 10.1017/S0022215124002172
Bhargavi Chandrasekar, Alexandra Bell, Andrew Kinshuck
{"title":"Prevalence and risk factors for dysplasia and malignancy in a large cohort of patients with recurrent respiratory papillomatosis.","authors":"Bhargavi Chandrasekar, Alexandra Bell, Andrew Kinshuck","doi":"10.1017/S0022215124002172","DOIUrl":"10.1017/S0022215124002172","url":null,"abstract":"","PeriodicalId":16293,"journal":{"name":"Journal of Laryngology and Otology","volume":" ","pages":"1-16"},"PeriodicalIF":1.1,"publicationDate":"2024-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142622295","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Squamous cell carcinoma of the posterior pharyngeal wall: A comparative analysis of oropharyngeal origin versus hypopharyngeal origin. 咽后壁鳞状细胞癌:口咽起源与下咽起源的比较分析。
IF 1.1 4区 医学 Q3 OTORHINOLARYNGOLOGY Pub Date : 2024-11-15 DOI: 10.1017/S002221512400224X
Petr Daniel Kovarik, Jakub Cvek, Rahul Patil, Charles Kelly, Malcolm Jackson, Laura McKenzie, Nick West, Nicholas Willis, Josef Paul Kovarik, Muhammad Shahid Iqbal
{"title":"Squamous cell carcinoma of the posterior pharyngeal wall: A comparative analysis of oropharyngeal origin versus hypopharyngeal origin.","authors":"Petr Daniel Kovarik, Jakub Cvek, Rahul Patil, Charles Kelly, Malcolm Jackson, Laura McKenzie, Nick West, Nicholas Willis, Josef Paul Kovarik, Muhammad Shahid Iqbal","doi":"10.1017/S002221512400224X","DOIUrl":"10.1017/S002221512400224X","url":null,"abstract":"","PeriodicalId":16293,"journal":{"name":"Journal of Laryngology and Otology","volume":" ","pages":"1-17"},"PeriodicalIF":1.1,"publicationDate":"2024-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142622298","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
"COMPARISON OF TRAGAL PERICHONDRIUM WITH CUBISM GRAFT IN ENDOSCOPIC TYMPANOPLASTY IN SMALL TO MEDIUM SIZE TYMPANIC MEMBRANE PERFORATIONS". "在中小型鼓膜穿孔的内窥镜鼓室成形术中,耳廓周软骨与立方体移植物的比较"。
IF 1.1 4区 医学 Q3 OTORHINOLARYNGOLOGY Pub Date : 2024-11-14 DOI: 10.1017/S0022215124002202
Nehal Lal, H C Taneja, Ravi Meher, Raman Sharma
{"title":"\"COMPARISON OF TRAGAL PERICHONDRIUM WITH CUBISM GRAFT IN ENDOSCOPIC TYMPANOPLASTY IN SMALL TO MEDIUM SIZE TYMPANIC MEMBRANE PERFORATIONS\".","authors":"Nehal Lal, H C Taneja, Ravi Meher, Raman Sharma","doi":"10.1017/S0022215124002202","DOIUrl":"https://doi.org/10.1017/S0022215124002202","url":null,"abstract":"","PeriodicalId":16293,"journal":{"name":"Journal of Laryngology and Otology","volume":" ","pages":"1-9"},"PeriodicalIF":1.1,"publicationDate":"2024-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142622143","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Post-operative management following endoscopic sinus surgery in the UK: a survey of The British Rhinological Society. 英国内窥镜鼻窦手术后的术后管理:英国鼻科学会调查。
IF 1.1 4区 医学 Q3 OTORHINOLARYNGOLOGY Pub Date : 2024-11-14 DOI: 10.1017/S0022215124002196
Loic Hayois, Peter Andrews, Samuel C Leong, Rishi Sharma, Neil Tan
{"title":"Post-operative management following endoscopic sinus surgery in the UK: a survey of The British Rhinological Society.","authors":"Loic Hayois, Peter Andrews, Samuel C Leong, Rishi Sharma, Neil Tan","doi":"10.1017/S0022215124002196","DOIUrl":"https://doi.org/10.1017/S0022215124002196","url":null,"abstract":"","PeriodicalId":16293,"journal":{"name":"Journal of Laryngology and Otology","volume":" ","pages":"1-21"},"PeriodicalIF":1.1,"publicationDate":"2024-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142622280","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Laryngology and Otology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1